Blum, Matthew F. https://orcid.org/0000-0003-4357-6926
Surapaneni, Aditya
Chang, Alexander
Inker, Lesley A.
Chen, Teresa K.
Appel, Lawrence J.
Shin, Jung-Im
Grams, Morgan E.
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (T32HL139426, K24HL155861)
National Institute of Diabetes and Digestive and Kidney Diseases (K01DK121825, R01DK115534)
Article History
Received: 13 September 2023
Accepted: 2 April 2024
First Online: 19 April 2024
Declarations:
:
: Dr. Blum reports grants or contracts: National Kidney Foundation and Johns Hopkins University; meeting or travel support: American Society of Nephrology. Dr. Chang reports grants or contracts: Bayer, Novartis, Novo Nordisk; consulting fees: Novartis, Reata, Amgen; data safety monitoring board or advisory board: Occurrence of Dyskalemia with Treatment for Hypertension Study. Dr. Inker reports grants or contracts: National Kidney Foundation, National Institutes of Health, Omeros, Dialysis Clinics Inc., Reata; consulting fees: Tufts Medical Center; data safety monitoring board or advisor board: Dimerix, TMC, Tricida, Healthlogistics. Dr. Chen reports grants or contracts: National Institutes of Health, Yale University; payment or honoraria: American Society of Nephrology; meeting or travel support: CKD Biomarkers Consortium Meeting. Dr. Grams reports grants or contracts: National Institutes of Health and National Kidney Foundation; payment or honoraria: University of Pennsylvania, Columbia University Medical Center, American Society of Nephrology; meeting/travel support: Kidney Disease Improving Global Outcomes, European Renal Association, University of Pennsylvania, and Korean Society of Nephrology; leadership or fiduciary role: American Society of Nephrology, Kidney Disease: Improving Global Outcomes, National Kidney Foundation, United States Renal Data System, American Society of Clinical Investigation, Clinical Journal of American Society of Nephrology, American Journal of Kidney Diseases, and Journal of American Society of Nephrology. The remaining authors declare that they have no relevant financial interests.